OraSure Technologies Inc

Find Ratings Reports
OSUR : NASDAQ : Health Care
$17.73 -0.27 | -1.5%
Today's Range: 17.43 - 18.13
Avg. Daily Volume: 890500.0
07/27/17 - 4:00 PM ET

Financial Analysis

ORASURE TECHNOLOGIES INC's gross profit margin for the first quarter of its fiscal year 2017 has decreased when compared to the same period a year ago. The company managed to grow both sales and net income at a faster pace than the average competitor in its industry this quarter as compared to the same quarter a year ago. ORASURE TECHNOLOGIES INC is extremely liquid. Currently, the Quick Ratio is 9.05 which clearly shows the ability to cover any short-term cash needs. OSUR managed to increase the liquidity from the same period a year ago, despite already having very strong liquidity to begin with. This would indicate improved cash flow.

At the same time, stockholders' equity ("net worth") has greatly increased by 28.10% from the same quarter last year. Overall, the key liquidity measurements indicate that the company is very unlikely to face financial difficulties in the near future.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.

Income Statement Q1 FY17 Q1 FY16
Net Sales ($mil)32.5529.09
EBITDA ($mil)4.784.05
EBIT ($mil)3.372.7
Net Income ($mil)12.442.45

Balance Sheet Q1 FY17 Q1 FY16
Cash & Equiv. ($mil)141.46102.25
Total Assets ($mil)232.59188.48
Total Debt ($mil)0.00.0
Equity ($mil)208.83163.02

Profitability Q1 FY17 Q1 FY16
Gross Profit Margin66.7374.49
EBITDA Margin14.6813.93
Operating Margin10.369.28
Sales Turnover0.570.65
Return on Assets12.775.57
Return on Equity14.226.44
Debt Q1 FY17 Q1 FY16
Current Ratio9.886.6
Interest Expense0.00.0
Interest Coverage0.00.0

Share Data Q1 FY17 Q1 FY16
Shares outstanding (mil)57.6655.48
Div / share0.00.0
Book value / share3.622.94
Institutional Own % n/a n/a
Avg Daily Volume875159.0976474.0


BUY. The current P/E ratio indicates a significant discount compared to an average of 47.54 for the Health Care Equipment & Supplies industry and a significant premium compared to the S&P 500 average of 24.66. For additional comparison, its price-to-book ratio of 5.07 indicates a significant premium versus the S&P 500 average of 3.07 and a discount versus the industry average of 5.47. The price-to-sales ratio is well above both the S&P 500 average and the industry average, indicating a premium. Upon assessment of these and other key valuation criteria, ORASURE TECHNOLOGIES INC proves to trade at a discount to investment alternatives within the industry.

1 2 3 4 5
premium   discount
  Price/Cash Flow
1 2 3 4 5
premium   discount
OSUR 35.31 Peers 47.54   OSUR 34.01 Peers 29.38

Discount. A lower P/E ratio than its peers can signify a less expensive stock or lower growth expectations.

OSUR is trading at a significant discount to its peers.


Premium. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures.

OSUR is trading at a premium to its peers.

1 2 3 4 5
premium   discount
  Price to
1 2 3 4 5
premium   discount
OSUR 57.38 Peers 25.74   OSUR 1.37 Peers 0.99

Premium. A higher price-to-projected earnings ratio than its peers can signify a more expensive stock or higher future growth expectations.

OSUR is trading at a significant premium to its peers.


Premium. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.

OSUR trades at a significant premium to its peers.

1 2 3 4 5
premium   discount
  Earnings Growth
1 2 3 4 5
lower   higher
OSUR 5.07 Peers 5.47   OSUR 188.88 Peers 113.75

Average. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.

OSUR is trading at a valuation on par with its peers.


Higher. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.

OSUR is expected to have an earnings growth rate that significantly exceeds its peers.

1 2 3 4 5
premium   discount
  Sales Growth
1 2 3 4 5
premium   discount
OSUR 8.04 Peers 5.22   OSUR 8.16 Peers 14.04

Premium. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.

OSUR is trading at a significant premium to its industry.


Lower. A sales growth rate that trails the industry implies that a company is losing market share.

OSUR significantly trails its peers on the basis of sales growth



Latest Stock Upgrades/Downgrades